Moderna Inc. buy UBS Group AG
Start price
19.02.25
/
50%
€34.80
Target price
19.02.26
€74.74
Performance (%)
1.22%
Price
09.02.26
€35.23
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 1.22%. This prediction currently runs until 19.02.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | -2.424% | -2.424% |
| iShares Core DAX® | 0.754% | -1.027% |
| iShares Nasdaq 100 | -2.859% | -4.266% |
| iShares Nikkei 225® | 4.946% | 5.736% |
| iShares S&P 500 | -1.254% | -2.357% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $96.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat